Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Neoplasm Metastasis 2Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Sarcoma 1Recurrence 1Neoplasm, Residual 1Melanoma 1Lung Neoplasms 1Core Binding Factor Acute Myeloid Leukemia 1Colorectal Neoplasms 1

Interventions

avapritinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Core Binding Factor Acute Myeloid Leukemia × avapritinib × Clear all
NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
50 enrolled
MyeloidOther hematologic neoplasm

Core Binding Factor Acute Myeloid Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡